Steward Partners Investment Advisory’s Kazia Therapeutics KZIA Stock Holding History

Steward Partners Investment Advisory’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1	Closed	-$25	–	3525
2023 Q3	$25	Hold	1	–	–	﹤0.01%	3355
2023 Q2	$29	Hold	1	–	–	﹤0.01%	3301
2023 Q1	$26	Sell	1 -1	-50%	-$48	﹤0.01%	3288
2022 Q4	$46	Hold	2	–	–	﹤0.01%	3317
2022 Q3	$0	Hold	2	–	–	﹤0.01%	3318
2022 Q2	$0	Hold	2	–	–	﹤0.01%	3312
2022 Q1	$1K	Hold	2	–	–	﹤0.01%	3194
2021 Q4	$1K	Hold	2	–	–	﹤0.01%	3101
2021 Q3	$1K	Hold	2	–	–	﹤0.01%	3085
2021 Q2	$1K	Hold	2	–	–	﹤0.01%	6972
2021 Q1	$1.24K	Hold	2	–	–	﹤0.01%	3292
2020 Q4	$1K	Hold	2	–	–	﹤0.01%	2791
2020 Q3	$1K	Sell	2 -5	-71%	-$1.41K	﹤0.01%	2670
2020 Q2	$1K	Hold	7	–	–	﹤0.01%	2584
2020 Q1	$0	Sell	7 -5	-42%	-$991	﹤0.01%	2608
2019 Q4	$2K	Hold	12	–	–	﹤0.01%	2432
2019 Q3	$2K	Hold	12	–	–	﹤0.01%	2436
2019 Q2	$1K	Buy	+12	New	+$1.84K	﹤0.01%	2538
2018 Q4	–	Sell	-11	Closed	-$2K	–	1517
2018 Q3	$2K	Buy	+11	New	+$1.87K	﹤0.01%	2378

Other funds holding KZIA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Steward Partners Investment Advisory's KZIA Position: Q4 2023 in Review

Steward Partners Investment Advisory sold out of Kazia Therapeutics (KZIA) in Q4 2023, closing a stake of 1 share — an estimated $25 sold.

Steward Partners Investment Advisory first reported a position in KZIA in Q3 2018 and held it in 19 quarters. The position peaked at $2K in Q4 2019. 17 funds tracked by Wall St. Rank hold KZIA as of Q4 2023.

Steward Partners Investment Advisory reported no remaining Kazia Therapeutics position as of Q4 2023 after selling out during the quarter.
Steward Partners Investment Advisory sold 1 Kazia Therapeutics share in Q4 2023, an estimated $25.
Steward Partners Investment Advisory first reported a position in Kazia Therapeutics in Q3 2018 and held it in 19 quarters.
Steward Partners Investment Advisory's Kazia Therapeutics position peaked at $2K in Q4 2019.
17 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q4 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2023, filed 12 Feb 2024.